PUMA BIOTECHNOLOGY, INC. Payments to Acquire Marketable Securities
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Payments to Acquire Marketable Securities of $44.38 million for the 36-month period ending 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2013-11-12
- PUMA BIOTECHNOLOGY, INC. payments to acquire marketable securities for the quarter ending 2013-09-30 was -$2.31M.
- PUMA BIOTECHNOLOGY, INC. payments to acquire marketable securities for the quarter ending 2013-06-30 was $19.60M.
- PUMA BIOTECHNOLOGY, INC. payments to acquire marketable securities for the quarter ending 2013-03-31 was $27.09M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 30 month | Payments to Acquire Marketable Securities 33 month | Payments to Acquire Marketable Securities 36 month |
|---|---|---|---|---|---|---|
| 2013-09-30 | -$2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $17.29M derived: sum of 2 quarters · filed 2013-11-12 | $44.38M 10-Q · filed 2013-11-12 | $44.38M 10-Q · filed 2013-11-12 | ||
| 2013-06-30 | $19.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $46.69M 10-Q · filed 2013-08-06 | $46.69M 10-Q · filed 2013-08-06 | |||
| 2013-03-31 | $27.09M 10-Q · filed 2013-05-09 | $27.09M 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |